Connection

Ivan Gentile to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Ivan Gentile has written about Antiviral Agents.
Ivan Gentile
Connection Strength
0.300
Antiviral Agents
  1. COVID-19: Time for Post-Exposure Prophylaxis? Int J Environ Res Public Health. 2020 Jun 04; 17(11).
    View in: PubMed
    Score: 0.082
  2. Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort. New Microbiol. 2019 Apr; 42(2):94-100.
    View in: PubMed
    Score: 0.076
  3. Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort). Hepatol Int. 2019 Jan; 13(1):66-74.
    View in: PubMed
    Score: 0.074
  4. Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection. Rev Recent Clin Trials. 2019; 14(3):173-182.
    View in: PubMed
    Score: 0.019
  5. Virological patterns of HCV patients with failure to interferon-free regimens. J Med Virol. 2018 05; 90(5):942-950.
    View in: PubMed
    Score: 0.017
  6. NS5B polymerase inhibitors in phase II clinical trials for HCV infection. Expert Opin Investig Drugs. 2018 03; 27(3):243-250.
    View in: PubMed
    Score: 0.017
  7. ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. Antivir Ther. 2017; 22(7):551-558.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.